Abstract Submissions are now closed.

If you have any questions, please contact [email protected]

General Presentation Guidelines
Southern Region Burn Conference

The deadline for submission of abstracts is on or before July 13, 2021, 4:30 pm CT. All submissions must be made using the online form.

  • Submission of an abstract constitutes a commitment by the author(s) to present if accepted. Acceptance of oral or poster presentation followed by no-show without cause and notification can result in a one year suspension of presenting privileges for the burn center.
  • Limitations: Submissions are limited to individuals, educational facilities, and hospitals. Commercial posters or presentations of any type are NOT permitted.
  • Notification: Upon approval by the Selections Committee, the presenting author will be notified by email of acceptance. The notification will include the scheduled date and time of the presentation. Notification will be sent on or before August 27, 2021.  It is the responsibility of the presenting author to notify additional authors of abstract acceptance.
  • Length of oral presentation:  Oral presentations will be 15-minute podium presentations with 10 minutes for presentation and 5 minutes for questions from the audience.
  • Setup of Posters:  SMA will provide a 4-foot TALL by 8-foot WIDE display board. Posters may be installed 3:00 - 7:00 pm Thursday, November 4 and beginning at 6:30 am on Friday, November 5. Posters MUST be in place by 7:00 am on Friday, November 5 for viewing.
  • Presentation of Posters: Posters will be available for viewing Friday, November 5 , 7:00 am through Saturday, November 6 at 10:00 am.  You should be prepared to discuss your work during poster rounds on Friday, November 5, 5:00-7:00 pm, during the Welcome Reception.
  • Poster Dismantle: Posters MUST be taken down by 12:00 pm on Saturday, November 6 or they will be destroyed.
  • Conflicts of Interest / Disclosure: Work submitted for presentation must include disclosure of ALL financial relationships with ineligible companies (if applicable). Conflicts of Interest will be mitigated prior to presentation.

Abstract Preparation

Before you begin, prepare the following information:

Presenting author’s contact details and information

  • Name and degree(s)
  • Affiliation details: academic title, department, institution, city, state
  • Email address
  • Full postal address
  • Phone number
  • Disclosure Information (including off-label discussions)

Co-authors’ details

  • Name(s) and degree(s)
  • Affiliation details: academic title, department, institution, city, state
  • Disclosure Information

Abstract title – limited to 25 words
Abstract text – no limitation on words
Abstracts should clearly state:

  • Introduction/Background (knowledge gap)
  • Methods/Design
  • Results/Findings
  • Conclusions/Implications
  • 2 -3 learning objectives

Use generic drug names. Trade names must not be used in the title or body of the abstract. If a trade name must be used, include trade names from multiple companies rather than a single company’s trade name.

Questions regarding submissions should be directed to [email protected] or (800) 423-4992.

Publication

  • Submission of an abstract acknowledges your approval for the abstract to be distributed to attendees at the meeting.
  • Accepted abstracts may be published in SMA’s electronic newsletter.

Registration Fees

Presenting authors must pay the applicable registration fee.  Submission of an abstract constitutes a commitment by the author(s) to present if accepted.

Please do not submit an abstract for consideration if your attendance at the conference is not approved or questionable.

Register Now

Travel Expenses: Reimbursement is not provided for hotel, air, or other travel expenses related to abstract presentations for the conference.

Presentation Tips

    • Use standard abbreviations.
    • Place special or unusual abbreviations in parentheses after the first time the full word appears.
    • Do not abbreviate compounds in the title of the abstract.
    • Use numerals to indicate numbers, except when beginning sentences.
    • Take special care when entering your title as it may be published online exactly as submitted.
    • Begin creating your presentation by determining the overall objectives:
      • What is the purpose of the presentation?
      • What are the main points you want to make?
      • Which points are the most important?
      • In what order should they be presented?
  • If you have to apologize for the appearance of a slide, it should not be shown.
  • Project every slide in as large a room as possible to evaluate appearance and readability.
  • Always bring your final presentation on a memory stick/flash drive.
  • Check your presentation against the following:
    • I have used a master slide (preferred) to maintain a similar format/background for all slides within my presentation.
    • I have used a sanserif font such as Arial rather than a serif font such as Times New Roman to enhance readability.
    • Slide backgrounds are not too dark or too bright.
    • Font sizes on slide titles are no smaller than 36 point and bullets are no smaller than 24 point.
    • Fonts are not dark over a dark background (for example, red or green on blue background).
    • I have avoided using bright orange and reds since they “play tricks” with eyes.
    • I have avoided red/green conflicts (20% of your audience has color impaired vision).
    • I have used a consistent font on all of my slides such as Arial.
    • I do not have more than eight lines per bullet slide (a bullet = a statement on the slide).
    • Information is short and to the point.
    • I do not have too many slides for the time allotted for my presentation.

Chart/Graph Slides

  • I have labeled all “x” and “y” axes.
  • If my axes are labeled, they are the same as the legend.
  • I have avoided over 3 lines per graph (limit of 2 is even better and less confusing).
  • I have avoided importing scanned graphs/spreadsheets (they do not project well and are very difficult to read).
  • I have used the graphing/spreadsheet function of the program instead of scanned graphs.

 PowerPoint Slides – Order of Presentation Checklist

  • Title Slide
    • Lecture title.
    • Your name and appropriate academic affiliation(s).
  • Disclosure Slide
    • List all relevant financial relationships related to the content you are presenting, or state, “I have no relevant financial relationships to disclose”
    • Indicate your intent to speak about unapproved/off-label FDA use.
  • Goals
    • The purpose of the lecture.
  • Objectives
    • What the attendee will learn as a result of listening to the lecture.
  • Content slides – things to remember:
    • Appropriately cite/reference each slide.
    • Use generic names vs. trade names for drug therapy whenever possible.
    • The number of slides in your lecture should not exceed your allotted time limit.
    • Provide a balanced view of therapeutic options or devices (if applicable).
    • DO NOT use slides or illustrations that are commercial in origin.
    • Request and obtain permission for any material that contains copyright.
  • Conclusion Slide
    • Summarize key points – relating back to the goals/objectives.
  • Resources/Suggested Reading
    • Provide additional articles/information to benefit the learner.

ACCME Standard and SMA disclosure and conflict of interest policies

  • In accordance with ACCME requirements and SMA policy, abstracts, selected for oral or poster presentation must be free of bias.
  • Do not reference any company/product brand names during your presentation. However, institution logos (e.g., non-company/product logos such as universities, non-profit associations and government agencies) are allowed in the body of your presentation.
  • SMA requires that educational materials that are part of a CME activity, such as slides, abstracts and handouts, not contain any advertising, trade names or a product group message.
  • Disclosures must never include the use of a trade name or a product group message.
  • For oral presentations, disclosures must be listed on the second slide of each presentation.
  • For poster presentations, disclosures must be listed once at the bottom of the poster.

New Standards for Integrity and Independence in Accredited Continuing Education

The ACCME's new Standards were released in December 2020, replacing the Standards for Commercial Support. Please note the updates and changes related to disclosure outlined below.

Identification and Mitigation of Relevant Financial Relationships of Planners, Faculty, and Others

Disclosure Information:

Disclosure information must be completed by Planners, Faculty, and all Others Who May Control Educational Content of an accredited activity. It is SMA’s responsibility to determine which relationships are relevant. You must disclose all financial relationships that you have had in the past 24 months with ineligible companies (see definition below). For each financial relationship, you must provide the name of the ineligible company and the nature of the financial relationship(s). There is no minimum financial threshold; we ask that you disclose all financial relationships, regardless of the amount, with ineligible companies. You should disclose all financial relationships regardless of the potential relevance of each relationship to the education. The requirement of disclosing for a spouse/guest has been removed.

Ineligible companies are organizations that are not eligible for accreditation (formerly known as commercial interests). This new term is intended to clarify that eligibility for accreditation is not based on whether an organization is for-profit or nonprofit but is based on its primary mission and function. 

Upon receipt of your disclosure information, SMA staff will:

  • Review your submitted disclosure information.Please note that owners or employees of ineligible companies will be excluded from participating as planners, speakers, authors, or faculty. 
  • Determine whether your financial relationships with ineligible companies disclosed (if any), are relevant to the content of the education being planned. Financial relationships are relevant if the following three conditions are met for the prospective person who will control content of the education:
    • A financial relationship, in any amount, exists between the person in control of content and an ineligible company.
    • The content of the education is related to the products of an ineligible company with whom the person has a financial relationship.
    • The financial relationship existed during the past 24 months.
  • Choose a mitigation strategy: For any person who has a relevant financial relationship, a strategy to mitigate (formerly known as “resolve”) the conflict will be implemented by SMA staff before the person assumes their role.

The following are examples of how the conflict may be mitigated:

Mitigation steps for planners:
✓ Divest the financial relationship
✓ Recusal from controlling aspects of planning and content with which there is a financial relationship
✓ Peer review of planning decisions by persons without relevant financial relationships

Mitigation steps for faculty, authors, and others
✓ Divest the financial relationship
✓ Peer review of content by persons without relevant financial relationships
✓ Attest that clinical recommendations are evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines)
✓ Use other methods (please describe):

Additional Information/Changes Related to Accredited Continuing Education

  • New: The term accredited continuing education replaces continuing medical education to be inclusive of all health professions. The word “accredited” is included to explicitly differentiate between accredited and nonaccredited education providers and education.
  • New: Individuals must disclose relationships with ineligible companies within the prior 24 months (changed from the current requirement of 12 months). 
  • Removed: Individuals no longer need to disclose the financial relationships of their spouse or partner. 
  • Clarified: Research grants from ineligible companies are financial relationships that should be disclosed, even if the funds go to the researcher’s institution and not to the individual researcher.  
  • Clarified: Owners or employees of ineligible companies must be excluded from controlling content.  
  • New: When disclosing relevant financial relationships to learners, accredited providers must include a statement that all relevant financial relationships have been mitigated.

Oral Abstract Presentation Guidelines
Southern Region Burn Conference

Refer to General Presentation Guidelines for additional information. The deadline for submission of abstracts is on or before July 13, 2021, 4:30 pm CT.

ACCEPTANCE NOTIFICATION

The presenting author will be notified by email of acceptance on or before August 27, 2021. You must respond by September 10 that you accept date/time. Failure to commit by the requested date may result in a replacement presentation.

Questions? Contact Kendra Blackmon by email [email protected] or 800-423-4992.

PRESENTATION GUIDELINES

All sessions will take place at the Hilton New Orleans Riverside Hotel, New Orleans, Louisiana. Upon arrival, stop by the SMA Registration Desk to pick up your meeting credentials, materials, and a copy of the final meeting program. We strongly recommend taking advantage of early registration on Thursday, 3:00-7:00 pm, to avoid the Friday morning rush when presentations are in progress.

Presentation:
Your presentation should be developed using Microsoft PowerPoint software. The length of the presentation will be 10 minutes for the presentation, plus 5 minutes for questions from the audience for a total of 15 minutes. Bring the final version of your presentation on a flash drive, ready to load, at least 4 hours prior to your start time to be loaded to the meeting room computer.

Audio/Visual Equipment Provided:
Microsoft PowerPoint is the required presentation method. The standard equipment listed below will be provided by SMA:

  • Lighted Lectern with Mic / Speaker’s Platform and Laser Pointer
  • Computer – Microsoft PowerPoint loaded
  • LCD Data Projector
  • Projection Screen

SYLLABUS MATERIALS

Your original abstract will be made available to attendees online prior to and during the meeting.

REGISTRATION AND HOUSING

All presenters must pre-register for the meeting no later than October 11, 2021. Registration will open on June 1, 2021. Housing information can be found at https://sma.org/burn.